A cohort study of childhood hypertrophic cardiomyopathy: Improved survival following high-dose beta-adrenoceptor antagonist treatment

Journal of the American College of Cardiology

Volumn 34, Issue 6, 1999, Pages 1813-1822

  Östman Smith, Ingegerd ^a   Wettrell, Göran ^b   Riesenfeld, Tomas ^c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DISOPYRAMIDE;

ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOLOGY; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; FOLLOW UP; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MORTALITY; PEDIATRICS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL;

ADRENERGIC BETA-ANTAGONISTS; CALCIUM CHANNEL BLOCKERS; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; COHORT STUDIES; HUMANS; NOONAN SYNDROME; PROPRANOLOL; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VERAPAMIL;

EID: 0033571197     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00421-0     Document Type: Article

References (34)

1. McKenna W, Deanfield J, Faruqui A, et al. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographs and hemodynamic features. Am J Cardiol 1981;47:532-8.
2. McKenna WJ, Deanfield JE. Hypertrophic cardiomyopathy: an important cause of sudden death. Arch Dis Child 1984;59:971-5.
3. Maron BJ, Henry NL, Clark CE, et al. Asymmetric septal hypertrophy in childhood. Circulation 1976;53:9-19.
4. Seiler C, Hess OM, Schoenbeck M, et al. Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study. J Am Coll Cardiol 1991;17:634-42.
5. Kofflard MJ, Waldstein DJ, Vos J, ten Gate FJ. Prognosis in hypertrophic cardiomyopathy observed in a large clinic population. Am J Cardiol 1993;72:939-43.
6. Maron BJ, Spinto P. Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history. Am J Cardiol 1993;72:970-2.
7. McKenna WJ, Oakley CM, Krikler DM, Goodwin JF. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J 1985;53:412-6.
8. Frank MJ, Abdulla AM, Canedo MI, Saylors RE. Long-term medical management of hypertrophic cardiomyopathy. Am J Cardiol 1978;42:993-1001.
9. Frank MJ, Stefadouros MA, Watkins LO, et al. Rhythm disturbances in hypertrophic cardiomyopathies: relationship to symptoms and the effect of complete' β-blockade. Eur Heart J 1983;4 Suppl F:235-43.
10. Bourmayan C, Dussaule JC, Artigou JY, et al. Evolution des myocardiopathies hypertrophiques et obstructives sous fortes doses de propranolol. Arch Mal Coeur Vaiss 1985;78:1409-16.
11. Shand DG, Sell CG, Oates JA. Hypertrophic obstructive cardiomyopathy in an infant: propranolol therapy for three years. N Engl J Med 1971;285:843-5.
12. Östman-Smith I, Wettrell G. Benefit from high-dose β-blocker therapy on survival and morbidity in childhood hypertrophic cardiomyopathy. In: Imai Y, Momma K, editors. Proceedings of the Second World Congress of Pediatric Cardiology and Cardiac Surgery. New York: Futura Publishing, 1998:241-4.
13. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949;37:161-86.
14. Silverman NH. Pediatric echocardiography. Baltimore: Williams & Wilkins, 1993.
15. Feigenbaum H. Echocardiography. 5th ed. Philadelphia: Lea & Febiger, 1991.
16. Marian AJ, Roberts R. Molecular genetics of hypertrophic cardiomyopathy. Annu Rev Med 1995;46:213-22.
17. Maron BJ, Spirito P, Wesley Y, Arce J. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med 1986;315:610-4.
18. Maron BJ, Roberts WC, Epstein S. Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation 1982;65:1388-94.
19. Östman-Smith I. Cardiac sympathetic nerves as the final common pathway in the induction of adaptive cardiac hypertrophy. Clin Sci 1981;61:265-72.
20. Östman-Smith I. Oral propranolol treatment reduces left ventricular hypertrophy secondary to pressure-overload in the rat. Br J Pharmacol 1995;116:2703-9.
21. Östman-Smith I. Beta-adrenoceptor blockade reduces hypoxia-induced right ventricular hypertrophy in the rat. Br J Pharmacol 1995;116:2698-702.
22. Brush JE, Eisenhofer G, Garty M, et al. Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy. Circulation 1989;79:836-44.
23. Shapiro LM. The differentiation of physiological from pathological left ventricular hypertrophy. In: Hunter S, Hall R, editors. Clinical echocardiography. Tunbridge Wells: Castle House Publications, 1986:25-32.
24. Maron BJ, Bonow RO, Cannon RO, et al. Hypertrophic cardiomyopathy: interrelation of clinical manifestations, pathophysiology and therapy. N Engl J Med 1987;316:780-9.
25. Alvares RF, Goodwin JF. Non-invasive assessment of diastolic function in hypertrophic cardiomyopathy on and off beta adrenergic blocking drugs. Br Heart J 1982;48:104-12.
26. Bourmayan C, Razavi A, Fournier C, et al. Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: an echographic study. Am Heart J 1985;109:1311-6.
27. McKenna WJ, Chetty S, Oakley CM, Goodwin JF. Arrhythmia in hypertrophic cardiomyopathy: exercise and 48-hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy. Am J Cardiol 1980;45:1-5.
28. Bourmayan C, Nouhaud M, Fournier C, et al. Arytmies ventriculaires de la myocardiopathie hypertrophie obstructive. Etude par enregistrement electrocardiographique continu. Presse Med 1983;12:2089-92.
29. Anderson JL. Symposium on the management of ventricular dysrhythmias: antifibrillatory versus antiectopic therapy. Am J Cardiol 1984;54:7a-13a.
30. Pollick C. Disopyramide in hypertrophic cardiomyopathy: II. Noninvasive assessment after oral administration. Am J Cardiol 1988;62:1252-5.
31. Matsubara H, Nakatani S, Nagata S, et al. Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1995;26:768-75.
32. Cokkinos DV, Salpeas D, Ioannou NE. Combination of disopyramide and propranolol in hypertrophic cardiomyopathy. Can J Cardiol 1989;5:33-6.
33. Nagashima M, Matsushima M, Ogawa A, et al. Cardiac arrhythmias in healthy children revealed by 24-hour ambulatory ECG-monitoring. Pediatr Cardiol 1987;8:103-8.
34. Yabek S. Ventricular arrhythmias in children with an apparently normal heart. J Pediatr 1991;119:1-11.